[sandbox] K4D COVID-19 Resource Hub

Sort by: Date tagged Date published

25 - 48 of 1176

A New Year’s Wish: Invest in Data

https://api.zotero.org/groups/2494380/items/YT449LCJ?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 08/25/2021

Health systems neglected by COVID-19 donors

https://api.zotero.org/groups/2494380/items/7DAUHA9N?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 08/25/2021

Equitable distribution of COVID-19 vaccines

https://api.zotero.org/groups/2494380/items/EJS4CAED?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 08/25/2021

Tuberculosis and malaria in the age of COVID-19

https://api.zotero.org/groups/2494380/items/I7RV5HYG?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 08/25/2021

6 Ways to Incorporate Social Context and Trust in Infodemic Management

https://api.zotero.org/groups/2494380/items/73CIEMSR?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 08/25/2021

Efforts to mitigate the economic impact of the COVID-19 pandemic: potential entry points for neglected tropical diseases

https://api.zotero.org/groups/2494380/items/J6B5SEXV?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 08/25/2021

Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial

https://api.zotero.org/groups/2494380/items/SVRERP5J?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 08/25/2021

Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses

https://api.zotero.org/groups/2494380/items/3YFJRYNX?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 08/24/2021

COVID-19: Make it the Last Pandemic

https://api.zotero.org/groups/2494380/items/KJIGAJ3Q?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 05/24/2021

Patterns of COVID-19 pandemic dynamics following deployment of a broad national immunization program

https://api.zotero.org/groups/2494380/items/9WCP5PAS?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 03/20/2021

Safety and efficacy of the ChAdOx1 nCoV-19 (AZD1222) Covid-19 vaccine against the B.1.351 variant in South Africa | medRxiv preprints (not peer reviewed)

https://api.zotero.org/groups/2494380/items/ZNFZ7EEU?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 03/20/2021

Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients

https://api.zotero.org/groups/2494380/items/GBLX58L4?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 03/20/2021

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

https://api.zotero.org/groups/2494380/items/SL42QCUQ?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 03/20/2021

Effectiveness of First Dose of COVID-19 Vaccines Against Hospital Admissions in Scotland: National Prospective Cohort Study of 5.4 Million People

https://api.zotero.org/groups/2494380/items/EYPWHUSF?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 03/20/2021

Prospective mapping of viral mutations that escape antibodies used to treat COVID-19

https://api.zotero.org/groups/2494380/items/Z6YZDGWG?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 03/20/2021

Inferring the effectiveness of government interventions against COVID-19

https://api.zotero.org/groups/2494380/items/KMN3WZGP?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 03/20/2021

Symptom reporting in over 1 million people: community detection of COVID-19 | medRxiv preprints (not peer reviewed)

https://api.zotero.org/groups/2494380/items/SX3E4KY3?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 03/20/2021

Africa's unfolding diet transformation: implications for agrifood system employment

https://api.zotero.org/groups/2494380/items/NBBIPHT7?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 01/29/2021

T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial

https://api.zotero.org/groups/2494380/items/87VE3UPH?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 01/16/2021

A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19

https://api.zotero.org/groups/2494380/items/MRPRFHAJ?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 01/16/2021

Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults

https://api.zotero.org/groups/2494380/items/92N23DYZ?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 01/16/2021

Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19 – Preliminary report

https://api.zotero.org/groups/2494380/items/U4CZTRXT?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 01/16/2021

Nosocomial Coronavirus Disease Outbreak Containment, Hanoi, Vietnam, March–April 2020 - Volume 27, Number 1—January 2021 - Emerging Infectious Diseases journal - CDC

https://api.zotero.org/groups/2494380/items/PS5MAB28?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 01/16/2021

Prior SARS-CoV-2 infection is associated with protection against symptomatic reinfection

https://api.zotero.org/groups/2494380/items/K768F4BT?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 01/16/2021

25 - 48 of 1176